Teva Pharmaceutical Industries Limited (LON:0LER)

Market Cap	30.53B +121.8%
Revenue (ttm)	13.05B +4.1%
Net Income	532.11M
EPS	0.45
Shares Out	n/a
PE Ratio	57.38
Forward PE	12.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,769
Open	34.10
Previous Close	34.84
Day's Range	34.36 - 34.84
52-Week Range	15.55 - 37.30
Beta	0.88
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About LON:0LER

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 32,008
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0LER

Financial Performance

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 7, 2026

Data Sources Report a data error